|
VICL, OMPI, MCGC, SFE, VG and WNS Expected To Be Lower After Earnings Releases on Thursday
(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, May 7th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and May earnings reports. Vical (NASDAQ: VICL), Obagi Medical Products (NASDAQ: OMPI), MCG Capital (NASDAQ: MCGC), Safeguard Scientifics (NYSE: SFE), Vonage (NYSE: VG) and WNS Holdings (NYSE: WNS) are all expected to be lower after their earnings are released Thursday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # or Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The technology used to make these predictions is available for a low monthly fee at www.squeezetrigger.com. The following stocks are expected to go lower after earnings are released Thursday:
Symbol Company # of Reports Quarter Release Time
VICL Vical Incorporated 6 quarters Q1 Before
OMPI Obagi Medical Products 6 quarters Q1 After
MCGC MCG Capital Corporation 12 quarters Q1 After
SFE Safeguard Scientifics May earnings Q1 Before
VG Vonage Holdings Corp. 12 quarters Q1 Before
WNS WNS (Holdings) Limited 6 quarters Q4 Before
Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event. because the information is so vital to the market's perception of the vitality of that company.
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
Vical Incorporated (NASDAQ: VICL) engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. It develops DNA-based vaccines and therapeutics for the prevention/treatment of infectious diseases, cardiovascular diseases, and cancer, including Allovectin-7 cancer immunotherapeutic, a Phase III clinical trial product for the treatment of metastatic melanoma; Therapeutic vaccine for cytomegalovirus, a Phase II clinical trial product to prevent viral reactivation and disease after transplant; Prophylactic vaccine for H5N1 pandemic influenza virus, which completed its Phase I clinical trial to protect against infection, disease, and/or viral shedding; Prophylactic vaccine for cytomegalovirus, a preclinical status product, which prevents infection before and during pregnancy to preclude fetal transmission; and Therapeutic vaccine for herpes simplex type 2 virus, a research status product that prevents recurring flare-ups. The company, through corporate collaborations, develops Collategene angiogenic therapy encoding Hepatocyte Growth Factor that induces local growth of blood vessels to restore blood flow to limbs affected by ischemia; Angiogenic therapy encoding Hepatocyte Growth Factor, which completed Phase I clinical trial, induces local growth of blood vessels to restore blood flow to heart affected by ischemia; Apex-IHN prophylactic vaccine that protects farm-raised salmon from infection and disease; and Therapeutic cancer vaccine encoding human tyrosinase, used in adjunct treatment to increase survival time of dogs with oral melanoma. It also has products in Phase I status that treat breast or prostate, colorectal, ovarian, or non-small cell lung cancer; melanoma; or carcinomas of the upper GI tract, colon, kidney, or bladder. Vical Incorporated was founded in 1987 and is based in San Diego, California.
Obagi Medical Products, Inc. (NASDAQ: OMPI), a specialty pharmaceutical company, develops and markets skincare products in the United States and internationally. The company develops and commercializes prescription-based, topical skin health systems, which enable physicians to treat a range of skin conditions. It offers Obagi Nu-Derm System, which includes prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo-damage, hyper pigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems, which are used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System, a combination of prescription, OTC drugs, and adjunctive cosmetic skin care products to treat skin conditions resulting from sun damage and the oxidative damage of free radicals; and Obagi Professional-C products, a line of proprietary, non-prescription products, which consist of vitamin C serums used to reduce the appearance of damage to the skin caused by ultraviolet radiation and other environmental influences. The company also offers ELASTIderm Eye and Decolletage, which increases the elasticity and skin tone of eyes, face, neckline, and chest; CLENZIderm M.D. Systems and SoluCLENZ Rx Gel for the treatment of acne; Obagi Rosaclear System, which is used for treating rosacea that reduces redness and flushing, as well as for the treatment of papules and pustules; Tretinoin, which is used for the treatment of acne in the United States; and Obagi Blue Peel System that is used for the treatment of fine lines, wrinkles, and hyper pigmentation. It markets its products through its domestic sales force and foreign distribution partners, as well as through the physician-dispensed skin channel to plastic surgeons, dermatologists, and other physicians that are focused on aesthetic and therapeutic skin care. The company was founded in 1988 and is headquartered in Long Beach, California.
MCG Capital Corporation (NASDAQ: MCGC) is a private equity firm specializing in investments in middle market companies. The firm is a publicly traded business development company. It seeks to invest in small to mid sized companies. The firm prefers to invest in acquisitions, growth financings, and leveraged buyouts. The firm seeks to invest in companies having revenues between $20 million and $200 million and EBITDA between $3 million and $25 million. It firm seeks to invest in the form of senior debt, including amortizing, bullet maturity term loans, and revolving credit facilities; second lien debt, that includes term loans on sole source and participant basis; secured and unsecured subordinate loans structured as current interest, deferred interest, and equity linked components; mezzanine debt; and equity that includes minority equity investments. It prefers to avoid investments in highly cyclical and volatile industry sectors and businesses with significant volatility exposure. The firm may invest in minority or control equity positions. It invests through the capital raised from the public equity markets. MCG Capital Corporation was founded in 1990 by Mr. Bryan J. Mitchell and Mr. B. Hagen Saville and is based in Arlington, Virginia.
Safeguard Scientifics, Inc. (NYSE: SFE) is a public investment firm specializing in expansion financing, growth capital, management buyout, recapitalization, industry consolidation, corporate spinout, and early stage financing transactions. The firm prefers to make investments in companies engaged in the technology and life sciences sectors. Within the technology sector it invests in software as a service, technology enabled services, and internet-based businesses. These include financial services; healthcare and life sciences; supply chain and logistics; analytics, B2B Internet, and business intelligence; enterprise applications; and infrastructure, security, and communication. In the life sciences sector it invests in drug formulation and delivery technologies; molecular diagnostics and medical devices; pharma services; specialty pharmaceuticals; products; and technology-enabled services in the life sciences sector. The firm invests throughout United States and Canada. It typically invests between $5 million and $50 million in portfolio companies. Specifically the firm invests between $25 million and $50 million in growth buyout financing, between $10 million and $25 million in growth equity financing, and $ 5 million and $10 million in early-stage financing. It typically invests in the following kinds of capital structures: owner financed and bootstrapped companies, corporate division or business unit, venture capital-backed that is seeking a growth partner, and Micro cap public companies. Safeguard Scientifics, Inc. was founded in 1953 and is based in Wayne, Pennsylvania with an additional office in Weston, Massachusetts.
Vonage Holdings Corp. (NASDAQ: VG), through its subsidiaries, provides broadband Voice over Internet Protocol services to residential and small business and home office customers. It offers various features, such as call waiting, caller ID with name, call forwarding, and voicemail. The company also provides area code selection, number portability, online account management, and personalized Web-enabled voicemail. In addition, it offers services, including Vonage visual voicemails, virtual phone numbers, toll free numbers, and residential and business fax services, as well as Vonage SoftPhone, a software application that is downloaded and installed on computers, laptops, and WiFi-enabled personal digital assistant devices, which enables user to use a computer as a telephone. Further, the company offers Vonage-enabled devices, such as Vonage V-Portal to connect up to two Vonage lines through a high-speed Internet connection and includes a networking router; analog telephone adapters, which convert analog audio signals into digital data packets for transmission over the Internet; integrated adapters and wireless routers; Vonage Bundled Cordless Phone; V-phone, a USB compatible device; and Vonage Companion, a downloadable softphone that can be loaded on a laptop or PC. As of December 31, 2008, it had approximately 2.6 million subscriber lines in service. The company was incorporated in 2000 and is headquartered in Holmdel, New Jersey.
WNS (Holdings) Limited (NYSE: WNS) provides offshore business process outsourcing services. Its services include data, voice, and analytical services. The company offers services to its clients through industry-focused business units, such as travel industry, including airlines, travel intermediaries, and other related service providers, for whom it perform services, such as customer service and revenue accounting; BFSI industry, for whom it perform services, such as loan processing and insurance claims management; industrial and infrastructure industry, including manufacturing, logistics, and utilities; and other industries comprising consumer products, retail, professional services, pharmaceutical, and media and entertainment. It also provides services applicable across multiple industries in various areas, such as finance and accounting, and knowledge services. The company has a joint venture with Advanced Contact Solutions, Inc., a BPO services and customer care provider in the Philippines, which offers contact center services to global clients across various industries. It has operations in India, Sri Lanka, the Philippines, Romania, Europe, and North America. WNS (Holdings) was founded in 1996 and is headquartered in Mumbai, India.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com
Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS LTD
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
Activate Email 
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.
